Infectious diseases and therapy

The most recent articles from: Infect Dis Ther December 2021

Infect Dis Ther · Dec 2021

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial.

Antiviral drugs have shown limited effectiveness in treating patients with coronavirus disease 2019 (COVID-19). We aimed to assess the effects of a favipiravir and hydroxychloroquine combination on treating moderate-to-severe COVID-19 patients. ⋯ ClinicalTrials.gov (NCT04392973).

explore more… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.